IN BRIEF: USD FDA accepts Takeda's TAK-003 for priority review
23 11월 2022 - 9:49PM
Alliance News
ical Co Ltd -
Tokyo-based biopharmaceutical company - Notes US Food & Drug
Administration has accepted and granted pri ...
Subscribe now to see this Premium News
article from
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
crowd.
- In The
Know - Management and analyst comments that go beyond company
announcements.
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
eurozone.
- Taking
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
started.
Takeda Pharmaceutical (LSE:0RN3)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Takeda Pharmaceutical (LSE:0RN3)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024